cabergoline has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cong, Z; Luo, X; Ma, C; Sun, R; Tang, C; Wen, G; Yang, J; Zhong, C; Zhu, J | 1 |
1 other study(ies) available for cabergoline and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
Article | Year |
---|---|
Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Bromocriptine; Cabergoline; Cell Line, Tumor; Early Growth Response Protein 1; Extracellular Signal-Regulated MAP Kinases; Female; Mice; Mice, Nude; Microtubule-Associated Proteins; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Proteins c-akt; Rats; RNA Interference; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |